Tuesday, 3 February, 2026
Isotopic imbalances of copper, zinc, and other essential metals in biological fluids open perspectives for early pathology detection and contaminant exposure monitoring.
IsoFind is not a healthcare provider. Our expertise focuses exclusively on isotopic signature analysis and interpretation. We intervene in support of medical teams and researchers to provide reliable data and analytical tools within the isotopic domain.
Copper and zinc play crucial roles in biological processes. Their isotopic imbalances in biological fluids or tissues are associated with certain pathologies, particularly cancers. Zinc dysregulation may signal inflammatory or tumoral processes, while copper, involved in angiogenesis, can indicate the progression of certain cancers.
In collaboration with research teams, we analyze these isotopic signatures to identify specific biomarkers, contributing to early detection and treatment efficacy monitoring.
Living organisms fractionate metal isotopes during metabolic processes: intestinal absorption, blood transport, hepatic storage, and renal excretion. Each step modifies isotopic ratios in measurable ways.
We support fundamental research projects exploring these fractionation patterns to better understand the regulatory mechanisms of essential metals in the human body, and the deviations associated with pathological states.
Chronic exposure to trace and heavy metals is a major public health concern. Stable isotopes identify exposure pathways (diet, water, inhalation) and discriminate contributing sources (natural, industrial, agricultural).
By analyzing isotopic signatures in biological matrices (blood, urine, hair), we bring epidemiological studies a level of resolution that elemental dosing alone cannot achieve.
We bring our isotopic expertise in support of your research teams, from analytical protocol design to data interpretation.
All Rights Reserved by IsoFind
